☆ 4.8 Article

Dual-responsive nanoparticles targeting bone microenvironment for synergistic chemoimmunotherapy of osteosarcoma by remodeling immune microenvironment

NANO TODAY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Engineering, Biomedical

Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy

Shu-Cheng Wan et al.

Summary: Pyroptosis triggers antitumor immunity and this study introduces a dual-responsive diselenide-based pyroptosis inducer that has excellent tumor microenvironment targeting effects. It can remodel the immunostimulated tumor microenvironment and trigger a robust immune response. Combined with αPD-1 therapy, it effectively inhibits the growth of remote tumors and prolongs survival.

ADVANCED HEALTHCARE MATERIALS (2023)

添加到收藏夹

Article Chemistry, Multidisciplinary

Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy

Xupeng Yang et al.

Summary: This study determines that reprogramming the metabolism of immature dendritic cells (iDCs) and tumor-associated macrophages (TAMs) can enhance the ratio of mature dendritic cells (mDCs) and proinflammatory macrophages, thus improving the immune response against triple-negative breast cancer. The findings provide a candidate method for monitoring treatment and augmenting antitumor chemoimmunotherapy by suppressing tumor cell autophagy and reprogramming immunocyte metabolism.

ACS NANO (2022)

添加到收藏夹

Article Oncology

MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells

Emeric Limagne et al.

Summary: Chemotherapy combined with MEK inhibitor enhances the sensitivity of lung cancer cells to immune checkpoint inhibitors by inducing CXCL10 expression and CD8(+) T cell recruitment. The study also highlights the role of TLR9- and OPTN-dependent mitophagy in enhancing the efficacy of chemoimmunotherapy.

CANCER CELL (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions

Ming Yi et al.

Summary: Antibodies targeting PD-1/PD-L1 revive immune response against cancer cells, but the low response rate calls for combination therapies. Combining with chemotherapy, radiotherapy, and other treatments can achieve better outcomes, and individualized combination selection is needed to overcome treatment resistance.

MOLECULAR CANCER (2022)

添加到收藏夹

Review Immunology

Immunogenic cell stress and death

Guido Kroemer et al.

Summary: Immunogenic cell death (ICD) plays an important role in therapy and disease, as dying mammalian cells release signals that interact with the host to determine the immunological correlates of cellular stress and death. ICD is crucial in immunosurveillance and is related to strategies evolved by pathogens and cancer cells. Additionally, normal cell death can also initiate antigen-specific immune responses.

NATURE IMMUNOLOGY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Photo-Reduction with NIR Light of Nucleus-Targeting PtIV Nanoparticles for Combined Tumor-Targeted Chemotherapy and Photodynamic Immunotherapy

Dengshuai Wei et al.

Summary: This study reports the use of Pt-IV-functionalized nanoparticles that can be excited within the MR region for multi-modal treatment. These nanoparticles selectively accumulate in tumor tissue and successfully eradicate breast cancer tumors.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment

Lulu Xue et al.

Summary: This study developed lipid nanoparticle formulations with a high affinity for the bone microenvironment, which overcame biological barriers and efficiently delivered mRNA therapeutics to the bone microenvironment. The results demonstrated the potential of these formulations for a range of therapeutic applications, including regenerative medicine and gene editing therapies.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis

Xin Guan et al.

Summary: Surgical resection often leads to tumor recurrence, impacting clinical outcomes. Novel nanosystem utilizing manganese dioxide shows promise in reducing cancer recurrence and metastasis post-surgery by targeting myeloid cells and relieving tumor hypoxia, ultimately enhancing response to radio-immunotherapy.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy

Yanhua Zhai et al.

Summary: In this study, self-activated arsenic manganite nanohybrids were developed for high-contrast magnetic resonance imaging (MRI) and arsenotherapy in triple-negative breast cancer (TNBC). The nanohybrids enabled precise tumor targeting, delivered high levels of arsenic trioxide (ATO) to the tumor cells, and exhibited potent antitumor efficacy. The nanohybrids also showed synergistic effects when combined with thermotherapy and induced immunogenic cell death (ICD) to activate the tumor microenvironment and enhance the antitumor immune response.

JOURNAL OF CONTROLLED RELEASE (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Photo-Reduction with NIR Light of Nucleus-Targetingt Pt-IV Nanoparticles for Combined Tumor-Targeted Chemotherapy and Photodynamic Immunotherapy

Dengshuai Wei et al.

Summary: The development of Pt-IV prodrugs selectively reduced into their Pt-II active species within cancerous cells has gained increasing attention. Despite progress, compounds are mostly excited using UV or blue light, limiting treatment for deep or large tumors. Pt-IV-functionalized nanoparticles excited at 808 nm within the MR region show potential for multi-modal treatment in eradicating tumors.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Serum protein-based nanoparticles for cancer diagnosis and treatment

Haroon Iqbal et al.

Summary: Serum protein, a versatile carrier in cancer nanomedicine, has shown superior biocompatibility and targeting capacity. Serum protein-based nanoparticles hold great potential for cancer treatment, but face challenges that need to be addressed for a bright future.

JOURNAL OF CONTROLLED RELEASE (2021)

添加到收藏夹

Article Oncology

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma

Ming Zeng et al.

Summary: Positive Ki-67 expression is significantly associated with Enneking stage, distant metastasis, and overall survival of osteosarcoma patients, suggesting it may serve as a potential biomarker for predicting prognosis and guiding clinical therapy.

BMC CANCER (2021)

添加到收藏夹

Article Oncology

Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs

Chenglong Chen et al.

Summary: Immunotherapy has shown promising efficacy in treating osteosarcoma, especially for metastatic or recurrent cases. Recent advancements in biomarker development have increased the number of patients benefiting from immunotherapies, offering hope to patients in need of new treatments.

CANCER LETTERS (2021)

添加到收藏夹

Review Medicine, General & Internal

New Horizons in the Treatment of Osteosarcoma

Paul S. Meltzer et al.

Summary: Osteosarcoma is a common malignant tumor that primarily affects individuals aged 10 to 30, and is usually treated with surgery and chemotherapy. While whole-genome sequencing can detect genetic alterations, it has not yet resulted in improved treatment outcomes.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Oncology

First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

George D. Demetri et al.

Summary: LRRC15 is a potential therapeutic target expressed in stromal fibroblasts in various solid tumor microenvironments, especially in sarcoma patients. ABBV-085, a LRRC15-targeting antibody-drug conjugate, demonstrated preliminary antitumor activity and safety in sarcoma patients at a dose of 3.6 mg/kg administered every 14 days, with no significant responses observed in other advanced cancer patients at the same dose.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Review Chemistry, Multidisciplinary

Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy

Masoud Delfi et al.

Summary: Self-assembled peptides and proteins have great potential as targeted drug delivery systems, especially in anti-cancer therapy. They can form diverse nanostructures in response to environmental conditions and offer good biocompatibility and high loading capacity for drugs, making them ideal for specific targeting of tumor cells.

NANO TODAY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

Kai Li et al.

Summary: MDSCs are a group of immunosuppressive cells that play a crucial role in tumor progression, affecting tumor development through various pathways and interfering with the efficacy of current anti-tumor therapies. Targeting MDSCs is a promising strategy for future cancer treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Review Multidisciplinary Sciences

Neoadjuvant checkpoint blockade for cancer immunotherapy

Suzanne L. Topalian et al.

SCIENCE (2020)

添加到收藏夹

Article Cell Biology

Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses

Jesse M. Jaynes et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Photosynthesis-inspired H2 generation using a chlorophyll-loaded liposomal nanoplatform to detect and scavenge excess ROS

Wei-Lin Wan et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Prodrug-Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death

Shuang Bai et al.

SMALL (2020)

添加到收藏夹

Review Cell Biology

The Roles of CD8(+) T Cell Subsets in Antitumor Immunity

Michael St Paul et al.

TRENDS IN CELL BIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion

Irene Rodriguez-Hernandez et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Review Immunology

Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy

Xiaopin Duan et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)

添加到收藏夹

Article Oncology

Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways

Li Wang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy

Bing Feng et al.

ADVANCED MATERIALS (2019)

添加到收藏夹

Article Oncology

Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis

Yu Han et al.

CANCER LETTERS (2019)

添加到收藏夹

Review Chemistry, Multidisciplinary

Engineered nanomedicines with enhanced tumor penetration

Jianxun Ding et al.

NANO TODAY (2019)

添加到收藏夹

Review Cell Biology

Tumor-associated macrophages: an accomplice in solid tumor progression

Yibing Chen et al.

JOURNAL OF BIOMEDICAL SCIENCE (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Host Cell Mimic Polymersomes for Rapid Detection of Highly Pathogenic Influenza Virus via a Viral Fusion and Cell Entry Mechanism

Hyun-Ouk Kim et al.

ADVANCED FUNCTIONAL MATERIALS (2018)

添加到收藏夹

Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment

Elisa Peranzoni et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery

Yun Xia et al.

CELL (2018)

添加到收藏夹

Review Cell Biology

Regulatory T cells in cancer immunotherapy

Atsushi Tanaka et al.

CELL RESEARCH (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Bacterial outer membrane vesicles suppress tumor by interferon-γ- mediated antitumor response

Oh Youn Kim et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Review Engineering, Biomedical

Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer

Robin A. Nadar et al.

ADVANCED HEALTHCARE MATERIALS (2017)

添加到收藏夹

Review Oncology

Cancer stem cells in osteosarcoma

Hannah K. Brown et al.

CANCER LETTERS (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

Versatile Prodrug Nanoparticles for Acid-Triggered Precise Imaging and Organelle-Specific Combination Cancer Therapy

Bing Feng et al.

ADVANCED FUNCTIONAL MATERIALS (2016)

添加到收藏夹

Review Chemistry, Multidisciplinary

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release

Nazila Kamaly et al.

CHEMICAL REVIEWS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis

Qian Yin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

添加到收藏夹

Review Biochemistry & Molecular Biology

Bone microenvironment signals in osteosarcoma development

Arantzazu Alfranca et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2015)

添加到收藏夹

Article Oncology

Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery

Franco M. Muggia et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Chemistry, Multidisciplinary

Multifunctional Albumin-MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response

Preethy Prasad et al.

ACS NANO (2014)

添加到收藏夹

Review Immunology

Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases

Alessandro Antonelli et al.

AUTOIMMUNITY REVIEWS (2014)

添加到收藏夹

Review Immunology

Immunogenic Cell Death in Cancer Therapy

Guido Kroemer et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)

添加到收藏夹

Article Oncology

Zoledronic Acid Reverses the Epithelial-Mesenchymal Transition and Inhibits Self-Renewal of Breast Cancer Cells through Inactivation of NF-κB

Amanda J. Schech et al.

MOLECULAR CANCER THERAPEUTICS (2013)

添加到收藏夹

Review Chemistry, Multidisciplinary

PLGA-based nanoparticles: An overview of biomedical applications

Fabienne Danhier et al.

JOURNAL OF CONTROLLED RELEASE (2012)

添加到收藏夹

Review Oncology

Immunogenic cell death and DAMPs in cancer therapy

Dmitri V. Krysko et al.

NATURE REVIEWS CANCER (2012)

添加到收藏夹

Article Oncology

Osteosarcoma

J. Ritter et al.

ANNALS OF ONCOLOGY (2010)

添加到收藏夹

Article Oncology

Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program

Lisa Mirabello et al.

CANCER (2009)

添加到收藏夹

Article Hematology

Of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNγ/Stat1 signals

Yu Yang et al.

BLOOD (2007)

添加到收藏夹

Article Hematology

Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid

Francesca Fiore et al.

BLOOD (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.